Publication Cover
New Genetics and Society
Critical Studies of Contemporary Biosciences
Volume 33, 2014 - Issue 2
316
Views
3
CrossRef citations to date
0
Altmetric
Articles

Managing expectational language: translational genetic professionals consider the clinical potential of next-generation sequencing technologies

&
Pages 126-148 | Received 03 Aug 2013, Accepted 13 Mar 2014, Published online: 19 May 2014

References

  • Akrich, M. 1992. “The De-scription of Technical Objects.” In Shaping Technology/Building Society: Studies in Sociotechnical Change, edited by W. E. Bijker and J. Law, 205–224. Cambridge, MA: MIT Press.
  • Akrich, M., J. Nunes, F. Paterson, & V. Rabeharisoa. 2008. The Dynamics of Patient Organizations in Europe. Paris: Presses des Mines.
  • Ashley, E. A., A. J. Butte, M. T. Wheeler, R. Chen, T. E. Klein, F. E. Dewey, J. T. Dudley, et al. 2010. “Clinical Assessment Incorporating a Personal Genome.” The Lancet 375 (9725): 1525–1535. doi: 10.1016/S0140-6736(10)60452-7
  • Barr, M., and D. Rose. 2008. “The Great Ambivalence: Factors Likely to Affect Service User and Public Acceptability of the Pharmacogenomics of Antidepressant Medication.” Sociology of Health & Illness 30 (6): 944–958. doi: 10.1111/j.1467-9566.2008.01116.x
  • Bates, B. R., J. A. Lynch, J. L. Bevan, and C. M. Condit. 2005. “Warranted Concerns Warranted Outlooks: A Focus Group Study of Public Understandings of Genetic Research.” Social Science & Medicine 60 (2): 331–344. doi: 10.1016/j.socscimed.2004.05.012
  • Baudhuin, L. M., L. J. Donato, and T. S. Uphoff. 2012. “How Novel Molecular Diagnostic Technologies and Biomarkers are Revolutionizing Genetic Testing and Patient Care.” Expert Review of Molecular Diagnostics 12 (1): 25–37. doi: 10.1586/erm.11.85
  • Bloss, C. S., N. J. Schork, and E. J. Topol. 2011. “Effect of Direct-to-Consumer Genome Wide Profiling to Assess Disease Risk.” New England Journal of Medicine 364 (6): 524–534. doi: 10.1056/NEJMoa1011893
  • Borup, M., N. Brown, K. Konrad, and H. Van Lente. 2006. “The Sociology of Expectations in Science and Technology.” Technology Analysis & Strategic Management 18 (3–4): 285–298. doi: 10.1080/09537320600777002
  • ten Bosch, J. R., and W. W. Grody. 2008. “Keeping up with the Next Generation: Massively Parallel Sequencing in Clinical Diagnostics.” The Journal of Molecular Diagnostics 10 (6): 484–492. doi: 10.2353/jmoldx.2008.080027
  • Brown, N. 2003. “Hope against Hype – Accountability in Biopasts Presents and Future.” Science Studies 16 (2): 3–21.
  • Brown, N., and M. Michael. 2003. “A Sociology of Expectations: Retrospecting Prospects and Prospecting Retrospects.” Technology Analysis and Strategic Management 15 (1): 3–18. doi: 10.1080/0953732032000046024
  • Brown, N., B. Rappert, and A. Webster. 2000. “Introducing Contested Futures: From Looking into the Future to Looking at the Future.” In Contested Futures: A Sociology of Prospective Technoscience, edited by N. Brown, B. Rappert, and A. Webster, 3–20. Aldershot: Ashgate.
  • Choi, M., U. I. Scholl, W. Ji, T. Liu, I. R. Tikhonova, P. Zumbo, A. Nayir, et al. 2009. “Genetic Diagnosis by Whole Exome Capture and Massively Parallel DNA Sequencing.” Proceedings of the National Academy of Sciences 106 (45): 19096–19101. doi: 10.1073/pnas.0910672106
  • Collins, H. M., and R. Evans. 2002. “The Third Wave of Science Studies: Studies of Expertise and Experience.” Social Studies of Science 32 (2): 235–296. doi: 10.1177/0306312702032002003
  • Condit, C. M. 1999. The Meanings of the Gene: Public Debates about Human Heredity. Madison: University of Wisconsin Press.
  • Condit, C. M., and J. Lynch. 2012. “Recent Rhetorical Studies in Public Understanding of Science: Multiple Purposes and Strengths.” Public Understanding of Science 21 (4): 386–400. doi: 10.1177/0963662512437330
  • Drmanac, R. M. 2012. “The Ultimate Genetic Test.” Science 336 (6085): 1110–1112. doi: 10.1126/science.1221037
  • Evans, J. P., E. M. Meslin, T. M. Marteau, and T. Caulfield. 2011. “Deflating the Genomic Bubble.” Science 331 (6019): 861–862. doi: 10.1126/science.1198039
  • Fortun, M. 2001. “Mediated Speculations in the Genomics Futures Market.” New Genetics and Society 20 (2): 139–156. doi: 10.1080/14636770124557
  • Fortun, M. 2008. Promising Genomics: Iceland and deCODE Genetics in a World of Speculation. Berkeley: University of California Press.
  • Friend, S. H., and T. Ideker. 2011. “POINT: Are We Prepared for the Future Doctor Visit?” Nature Biotechnology 29 (3): 215–218. doi: 10.1038/nbt.1794
  • Harvey, A. 2009. “From Genetic Risk to Post-genomic Uncertainties: Nutrigenomics and the Birth of the Genetic Entrepreneur.” New Genetics and Society 28 (2): 119–137. doi: 10.1080/14636770902901447
  • Hedgecoe, A. 2004. The Politics of Personalized Medicine: Pharmacogenetics in the Clinic. New York: Cambridge University Press.
  • Hedgecoe, A. 2006. “Pharmacogenetics as Alien Science: Alzheimer's Disease Core Sets and Expectations.” Social Studies of Science 36 (5): 723–752. doi: 10.1177/0306312706059746
  • Hedgecoe, A., and P. Martin. 2003. “The Drugs Don't Work: Expectations and the Shaping of Pharmacogenetics.” Social Studies of Science 33 (3): 327–364. doi: 10.1177/03063127030333002
  • Hock, K. T., K. D. Christensen, B. M. Yashar, J. S. Roberts, S. E. Gollust, and W. R. Uhlmann. 2011. “Direct-to-Consumer Genetic Testing: An Assessment of Genetic Counselors’ Knowledge and Beliefs.” Genetics in Medicine 13 (4): 325–332. doi: 10.1097/GIM.0b013e3182011636
  • Hörig, H., E. Marincola, and F. M. Marincola. 2005. “Obstacles and Opportunities in Translational Research.” Nature Medicine 11 (7): 705–708. doi: 10.1038/nm0705-705
  • Horst, M. 2007. “Public Expectations of Gene Therapy: Scientific Futures and Their Performative Effects on Scientific Citizenship.” Science Technology & Human Values 32 (2): 150–171. doi: 10.1177/0162243906296852
  • Kingsmore, S. F., and C. J. Saunders. 2011. “Deep Sequencing of Patient Genomes for Disease Diagnosis: When Will It Be Routine?” Science Translational Medicine 3 (87): 87ps23. doi: 10.1126/scitranslmed.3002695
  • Kitzinger, J. 1994. “The Methodology of Focus Groups: The Importance of Interaction Between Research Participants.” Sociology of Health & Illness 16 (1): 103–121. doi: 10.1111/1467-9566.ep11347023
  • Kitzinger, J., and C. Williams. 2005. “Forecasting Science Futures: Legitimising Hope and Calming Fears in the Embryo Stem Cell Debate.” Social Science & Medicine 61: 731–740. doi: 10.1016/j.socscimed.2005.03.018
  • Klee, E. W., N. L. Hoppman-Chaney, and M. J. Ferber. 2011. “Expanding DNA Diagnostic Panel Testing: Is More Better?” Expert Review of Molecular Diagnostics 11 (7): 703–711. doi: 10.1586/erm.11.58
  • Koboldt, D. C., K. M. Steinberg, D. E. Larson, R. K. Wilson, and E. R. Mardis. 2013. “The Next-Generation Sequencing Revolution and its Impact on Genomics.” Cell 155 (1): 27–38. doi: 10.1016/j.cell.2013.09.006
  • Kreiner, T., and K. T. Buck. 2005. “Moving Toward Whole-Genome Analysis: A Technology Perspective.” American Journal of Health-System Pharmacy 62 (3): 296–305.
  • Ku, C. S., D. N. Cooper, C. Polychronakos, N. Naidoo, M. Wu, and R. Soong. 2012. “Exome Sequencing: Dual Role as a Discovery and Diagnostic Tool.” Annals of Neurology 71 (1): 5–14. doi: 10.1002/ana.22647
  • Lupski, J. R., J. G. Reid, C. Gonzaga-Jauregui, D. R. Deiros, D. C. Y. Chen, L. Nazareth, M. Bainbridge et al. 2010. “Whole-Genome Sequencing in a Patient with Charcot-Marie-Tooth Neuropathy.” New England Journal of Medicine 362 (13): 1181–1191. doi: 10.1056/NEJMoa0908094
  • Mankoff, S. P., C. Brander, S. Ferrone, and F. M. Marincola. 2004. “Lost in Translation: Obstacles to Translational Medicine.” Journal of Translational Medicine 2 (1): 14–18. doi: 10.1186/1479-5876-2-14
  • Martin, P., N. Brown, and A. Kraft. 2008. “From Bedside to Bench? Communities of Promise Translational Research and the Making of Blood Stem Cells.” Science as Culture 17 (1): 29–41. doi: 10.1080/09505430701872921
  • Martin, P., N. Brown, and A. Turner. 2008. “Capitalizing Hope: The Commercial Development of Umbilical Cord Blood Stem Cell Banking.” New Genetics and Society 27 (2): 127–143. doi: 10.1080/14636770802077074
  • McBride, C. M., C. Wade, and K. A. Kaphingst. 2010. “Consumers’ Views of Direct-to-Consumer Genetic Information.” Annual Review of Genomics & Human Genetics 11: 427–446. doi: 10.1146/annurev-genom-082509-141604
  • McGowan, M., J. Fishman, and M. Lambrix. 2010. “Personal Genomics and Individual Identities: Motivations and Moral Imperatives of Early Users.” New Genetics and Society 29 (3): 261–290. doi: 10.1080/14636778.2010.507485
  • McGuire, A. L., C. M. Diaz, T. Wang, and S. G. Hilsenbeck. 2009. “Social Networkers’ Attitudes Toward Direct-to-Consumer Personal Genome Testing.” American Journal of Bioethics 9 (6–7): 3–10. doi: 10.1080/15265160902928209
  • Meyerson, M., S. Gabriel, and G. Getz. 2010. “Advances in Understanding Cancer Genomes Through Second-Generation Sequencing.” Nature Reviews Genetics 11 (10): 685–696. doi: 10.1038/nrg2841
  • Michael, M., S. Wainwright, C. Williams, B. Farsides, and A. Cribb. 2007. “From Core Set to Assemblage: On the Dynamics of Exclusion and Inclusion in the Failure to Derive Beta Cells from Embryonic Stem Cells.” Science Studies 20 (1): 5–25.
  • Moreira, T., and P. Palladino. 2005. “Between Truth and Hope: On Parkinson's Disease Neurotransplantation and the Production of the Self.” History of the Human Sciences 18 (3): 55–82. doi: 10.1177/0952695105059306
  • Nelkin, D. 1995. Selling Science: How the Press Covers Science. New York: W.H. Freeman.
  • Nelkin, D., and S. Lindee. 1995. The DNA Mystique: The Gene as a Cultural Icon. New York: W.H. Freeman.
  • Nerlich, B., and C. Halliday. 2007. “Avian Flu: The Creation of Expectations in the Interplay Between Science and the Media.” Sociology of Health & Illness 29 (1): 46–65. doi: 10.1111/j.1467-9566.2007.00517.x
  • Novas, C. 2006. “The Political Economy of Hope: Patients’ Organizations Science and Biovalue.” BioSocieties 1 (3): 289–305. doi: 10.1017/S1745855206003024
  • O'Daniel, J. M., S. B. Haga, and H. F. Willard. 2010. “Considerations for the Impact of Personal Genome Information: A Study of Genomic Profiling among Genetics and Genomic Professionals.” Journal of Genetic Counseling 19 (4): 387–401. doi: 10.1007/s10897-010-9297-x
  • O'Rourke, P. P. 2013. “Genomic Medicine: Too Great Expectations?” Clinical Pharmacology & Therapeutics 94 (2): 188–190. doi: 10.1038/clpt.2013.44
  • Oudshoorn, N., and T. J. Pinch, eds. 2003. How Users Matter: The Co-construction of Users and Technologies. Cambridge, MA: MIT Press.
  • Petersen, A. 2001. “Biofantasies: Genetics and Medicine in the Print News Media.” Social Science & Medicine 52 (8): 1255–1268. doi: 10.1016/S0277-9536(00)00229-X
  • Petersen, A., and K. Seear. Dec 2011. “Technologies of Hope: Techniques of the Online Advertising of Stem Cell Treatments.” New Genetics and Society 30 (4): 329–346. doi: 10.1080/14636778.2011.592003
  • Pettersson, E., J. Lundeberg, and A. Ahmadian. 2008. “Generations of Sequencing Technologies.” Genomics 93 (2): 105–111. doi: 10.1016/j.ygeno.2008.10.003
  • Powell, K. P., W. A. Cogswell, C. A. Christianson, G. Dave, A. Verma, S. Eubanks, and V. C. Henrich. 2011. “Primary Care Physicians’ Awareness Experience and Opinions of Direct-to-Consumer Genetic Testing.” Journal of Genetic Counseling 21 (1): 113–126. doi: 10.1007/s10897-011-9390-9
  • Raffan, E., and R. K. Semple. 2011. “Next Generation Sequencing – Implications for Clinical Practice.” British Medical Bulletin 99 (1): 53–71. doi: 10.1093/bmb/ldr029
  • Rajan, K. S. 2006. Biocapital: The Constitution of Postgenomic Life. Durham, NC: Duke University Press.
  • Rappert, B. 1999. “Rationalising the Future? Foresight in Science and Technology Policy Co-ordination.” Futures 31 (6): 527–545. doi: 10.1016/S0016-3287(99)00012-9
  • Rappert, B., and N. Brown. 2000. “Putting the Future in Its Place: Comparing Innovation Moments in Genetic Diagnostics and Telemedicine.” New Genetics and Society 19 (1): 49–75. doi: 10.1080/14636770050002955
  • Roberts, N. J., J. T. Vogelstein, G. Parmigiani, K. W. Kinzler, B. Vogelstein, and V. E. Velculescu. 2012. “The Predictive Capacity of Personal Genome Sequencing.” Science Translational Medicine 4 (133): 133–158. doi: 10.1126/scitranslmed.3003380
  • Rosengarten, M., and M. Michael. 2009. “The Performative Function of Expectations in Translating Treatment to Prevention: The Case of HIV Pre-exposure Prophylaxis PrEP.” Social Science & Medicine 69 (7): 1049–1055. doi: 10.1016/j.socscimed.2009.07.039
  • Ross, J. S., and M. Cronin. 2011. “Whole Cancer Genome Sequencing by Next-Generation Methods.” American Journal of Clinical Pathology 136 (4): 527–539. doi: 10.1309/AJCPR1SVT1VHUGXW
  • Schadt, E. E., S. Turner, and A. Kasarskis. 2010. “A Window into Third-Generation Sequencing.” Human Molecular Genetics 19 (Rev. Iss. 2): R227–R240. doi: 10.1093/hmg/ddq416
  • Selin, C. 2007. “Expectations and the Emergence of Nanotechnology.” Science Technology & Human Values 32 (2): 196–220. doi: 10.1177/0162243906296918
  • Selin, C. 2008. “The Sociology of the Future: Tracing Stories of Technology and Time.” Sociology Compass 2 (6): 1878–1895. doi: 10.1111/j.1751-9020.2008.00147.x
  • Stewart, D. W., P. N. Shamdesani, and D. W. Rook. 2007. Focus Groups: Theory and Practice. Thousand Oaks, CA: Sage.
  • Tucker, T., M. Marra, and J. M. Friedman. 2009. “Massively Parallel Sequencing: The Next Big Thing in Genetic Medicine.” American Journal of Human Genetics 85 (2): 142–154. doi: 10.1016/j.ajhg.2009.06.022
  • Turney, J. 1998. Frankensteins Footsteps: Science Genetics and Popular Culture. New Haven, CT: Yale University Press.
  • Tutton, R. 2007. “Constructing Participation in Genetic Databases: Citizen Governance and Ambivalence.” Science Technology and Human Values 32 (2): 172–195. doi: 10.1177/0162243906296853
  • Tutton, R. 2011. “Promising Pessimism: Reading the Futures to Be Avoided in Biotech.” Social Studies of Science 41 (3): 411–429. doi: 10.1177/0306312710397398
  • Tutton, R., A. Smart, P. A. Martin, R. Ashcroft, and G. T. H. Ellison. 2008. “Genotyping the Future: Scientists’ Expectations about Race/Ethnicity after BiDil.” Journal of Law Medicine & Ethics 36 (3): 464–470. doi: 10.1111/j.1748-720X.2008.292.x
  • Uhlmann, W. R., and R. S. Sharp. 2012. “Genetic Testing Integration Panels (GTIP): A Novel Approach for Considering Integration of Direct-to-Consumer and Other New Genetic Tests into Patient Care.” Journal of Genetic Counseling 21 (3): 374–381. doi: 10.1007/s10897-011-9468-4
  • Van Dijck, Jose. 1997. Imagenation: Popular Images of Genetics. New York: NYU Press.
  • Van Lente, H., and A. Rip. 1998. “The Rise of Membrane Technology: From Rhetorics to Social Reality.” Social Studies of Science 28 (2): 221–254. doi: 10.1177/030631298028002002
  • Voelkerding, K. V., S. Dames, and J. D. Durtschi. 2010. “Voelkerding a Paper from the 2009 William Beaumont Hospital Symposium on Molecular Pathology.” The Journal of Molecular Diagnostics 12 (5): 539–551. doi: 10.2353/jmoldx.2010.100043
  • Wainwright, S. P., C. Williams, M. Michael, B. Farsides, and A. Cribb. 2006. “From Bench to Bedside? Biomedical Scientists’ Expectations of Stem Cell Science as a Future Therapy for Diabetes.” Social Studies of Medicine 63 (8): 2052–2064. doi: 10.1016/j.socscimed.2006.05.003
  • Ware, S. M. 2011. “Genetic Diagnosis in Pediatric Cardiomyopathy: Clinical Application and Research Perspectives.” Progress in Pediatric Cardiology 31 (2): 99–102. doi: 10.1016/j.ppedcard.2011.02.006
  • Webster, A., C. Douglas, and G. Lewis. 2009. “Making Sense of Medicines: Lay Pharmacology and Narratives of Safety and Efficacy.” Science as Culture 18 (2): 233–247. doi: 10.1080/09505430902885631
  • Zhao, J., and S. F. A. Grant. 2011. “Advances in Whole Genome Sequencing Technology.” Current Pharmaceutical Biotechnology 12 (2): 293–305. doi: 10.2174/138920111794295729

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.